Global Human Coagulation Factor VIII Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Summary
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.
According to APO Research, The global Human Coagulation Factor VIII market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Human Coagulation Factor VIII include Shire (Baxter), Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, NovoNordisk and Greencross, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Human Coagulation Factor VIII, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Human Coagulation Factor VIII, also provides the sales of main regions and countries. Of the upcoming market potential for Human Coagulation Factor VIII, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Coagulation Factor VIII sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Human Coagulation Factor VIII market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Human Coagulation Factor VIII sales, projected growth trends, production technology, application and end-user industry.
Human Coagulation Factor VIII segment by Company
1. To analyze and research the global Human Coagulation Factor VIII status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Human Coagulation Factor VIII market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Human Coagulation Factor VIII significant trends, drivers, influence factors in global and regions.
6. To analyze Human Coagulation Factor VIII competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Coagulation Factor VIII market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Coagulation Factor VIII and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Coagulation Factor VIII.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Human Coagulation Factor VIII market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human Coagulation Factor VIII industry.
Chapter 3: Detailed analysis of Human Coagulation Factor VIII manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Human Coagulation Factor VIII in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Human Coagulation Factor VIII in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.
According to APO Research, The global Human Coagulation Factor VIII market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Human Coagulation Factor VIII include Shire (Baxter), Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, NovoNordisk and Greencross, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Human Coagulation Factor VIII, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Human Coagulation Factor VIII, also provides the sales of main regions and countries. Of the upcoming market potential for Human Coagulation Factor VIII, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Coagulation Factor VIII sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Human Coagulation Factor VIII market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Human Coagulation Factor VIII sales, projected growth trends, production technology, application and end-user industry.
Human Coagulation Factor VIII segment by Company
- Shire (Baxter)
- Bayer
- CSL
- Pfizer
- Grifols
- Biogen
- Octapharma
- NovoNordisk
- Greencross
- Kedrion
- BPL
- Hualan Bio
- RAAS
- Recombinant Factor VIII
- Plasma-derived Factor VIII
- Hemophilia A
- Spontanous / Trauma
- Surgical
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Human Coagulation Factor VIII status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Human Coagulation Factor VIII market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Human Coagulation Factor VIII significant trends, drivers, influence factors in global and regions.
6. To analyze Human Coagulation Factor VIII competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Coagulation Factor VIII market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Coagulation Factor VIII and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Coagulation Factor VIII.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Human Coagulation Factor VIII market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human Coagulation Factor VIII industry.
Chapter 3: Detailed analysis of Human Coagulation Factor VIII manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Human Coagulation Factor VIII in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Human Coagulation Factor VIII in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Human Coagulation Factor VIII Sales Value (2019-2030)
1.2.2 Global Human Coagulation Factor VIII Sales Volume (2019-2030)
1.2.3 Global Human Coagulation Factor VIII Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 HUMAN COAGULATION FACTOR VIII MARKET DYNAMICS
2.1 Human Coagulation Factor VIII Industry Trends
2.2 Human Coagulation Factor VIII Industry Drivers
2.3 Human Coagulation Factor VIII Industry Opportunities and Challenges
2.4 Human Coagulation Factor VIII Industry Restraints
3 HUMAN COAGULATION FACTOR VIII MARKET BY COMPANY
3.1 Global Human Coagulation Factor VIII Company Revenue Ranking in 2023
3.2 Global Human Coagulation Factor VIII Revenue by Company (2019-2024)
3.3 Global Human Coagulation Factor VIII Sales Volume by Company (2019-2024)
3.4 Global Human Coagulation Factor VIII Average Price by Company (2019-2024)
3.5 Global Human Coagulation Factor VIII Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Human Coagulation Factor VIII Company Manufacturing Base & Headquarters
3.7 Global Human Coagulation Factor VIII Company, Product Type & Application
3.8 Global Human Coagulation Factor VIII Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Human Coagulation Factor VIII Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Human Coagulation Factor VIII Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 HUMAN COAGULATION FACTOR VIII MARKET BY TYPE
4.1 Human Coagulation Factor VIII Type Introduction
4.1.1 Recombinant Factor VIII
4.1.2 Plasma-derived Factor VIII
4.2 Global Human Coagulation Factor VIII Sales Volume by Type
4.2.1 Global Human Coagulation Factor VIII Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Human Coagulation Factor VIII Sales Volume by Type (2019-2030)
4.2.3 Global Human Coagulation Factor VIII Sales Volume Share by Type (2019-2030)
4.3 Global Human Coagulation Factor VIII Sales Value by Type
4.3.1 Global Human Coagulation Factor VIII Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Human Coagulation Factor VIII Sales Value by Type (2019-2030)
4.3.3 Global Human Coagulation Factor VIII Sales Value Share by Type (2019-2030)
5 HUMAN COAGULATION FACTOR VIII MARKET BY APPLICATION
5.1 Human Coagulation Factor VIII Application Introduction
5.1.1 Hemophilia A
5.1.2 Spontanous / Trauma
5.1.3 Surgical
5.1.4 Other
5.2 Global Human Coagulation Factor VIII Sales Volume by Application
5.2.1 Global Human Coagulation Factor VIII Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Human Coagulation Factor VIII Sales Volume by Application (2019-2030)
5.2.3 Global Human Coagulation Factor VIII Sales Volume Share by Application (2019-2030)
5.3 Global Human Coagulation Factor VIII Sales Value by Application
5.3.1 Global Human Coagulation Factor VIII Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Human Coagulation Factor VIII Sales Value by Application (2019-2030)
5.3.3 Global Human Coagulation Factor VIII Sales Value Share by Application (2019-2030)
6 HUMAN COAGULATION FACTOR VIII MARKET BY REGION
6.1 Global Human Coagulation Factor VIII Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Human Coagulation Factor VIII Sales by Region (2019-2030)
6.2.1 Global Human Coagulation Factor VIII Sales by Region: 2019-2024
6.2.2 Global Human Coagulation Factor VIII Sales by Region (2025-2030)
6.3 Global Human Coagulation Factor VIII Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Human Coagulation Factor VIII Sales Value by Region (2019-2030)
6.4.1 Global Human Coagulation Factor VIII Sales Value by Region: 2019-2024
6.4.2 Global Human Coagulation Factor VIII Sales Value by Region (2025-2030)
6.5 Global Human Coagulation Factor VIII Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Human Coagulation Factor VIII Sales Value (2019-2030)
6.6.2 North America Human Coagulation Factor VIII Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Human Coagulation Factor VIII Sales Value (2019-2030)
6.7.2 Europe Human Coagulation Factor VIII Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Human Coagulation Factor VIII Sales Value (2019-2030)
6.8.2 Asia-Pacific Human Coagulation Factor VIII Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Human Coagulation Factor VIII Sales Value (2019-2030)
6.9.2 Latin America Human Coagulation Factor VIII Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Human Coagulation Factor VIII Sales Value (2019-2030)
6.10.2 Middle East & Africa Human Coagulation Factor VIII Sales Value Share by Country, 2023 VS 2030
7 HUMAN COAGULATION FACTOR VIII MARKET BY COUNTRY
7.1 Global Human Coagulation Factor VIII Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Human Coagulation Factor VIII Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Human Coagulation Factor VIII Sales by Country (2019-2030)
7.3.1 Global Human Coagulation Factor VIII Sales by Country (2019-2024)
7.3.2 Global Human Coagulation Factor VIII Sales by Country (2025-2030)
7.4 Global Human Coagulation Factor VIII Sales Value by Country (2019-2030)
7.4.1 Global Human Coagulation Factor VIII Sales Value by Country (2019-2024)
7.4.2 Global Human Coagulation Factor VIII Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.5.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.6.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.7.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.8.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.9.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.10.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.11.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.12.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.13.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.14.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.15.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.16.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.17.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.18.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.19.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.20.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.21.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.22.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.23.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Shire (Baxter)
8.1.1 Shire (Baxter) Comapny Information
8.1.2 Shire (Baxter) Business Overview
8.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.1.4 Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
8.1.5 Shire (Baxter) Recent Developments
8.2 Bayer
8.2.1 Bayer Comapny Information
8.2.2 Bayer Business Overview
8.2.3 Bayer Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.2.4 Bayer Human Coagulation Factor VIII Product Portfolio
8.2.5 Bayer Recent Developments
8.3 CSL
8.3.1 CSL Comapny Information
8.3.2 CSL Business Overview
8.3.3 CSL Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.3.4 CSL Human Coagulation Factor VIII Product Portfolio
8.3.5 CSL Recent Developments
8.4 Pfizer
8.4.1 Pfizer Comapny Information
8.4.2 Pfizer Business Overview
8.4.3 Pfizer Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.4.4 Pfizer Human Coagulation Factor VIII Product Portfolio
8.4.5 Pfizer Recent Developments
8.5 Grifols
8.5.1 Grifols Comapny Information
8.5.2 Grifols Business Overview
8.5.3 Grifols Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.5.4 Grifols Human Coagulation Factor VIII Product Portfolio
8.5.5 Grifols Recent Developments
8.6 Biogen
8.6.1 Biogen Comapny Information
8.6.2 Biogen Business Overview
8.6.3 Biogen Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.6.4 Biogen Human Coagulation Factor VIII Product Portfolio
8.6.5 Biogen Recent Developments
8.7 Octapharma
8.7.1 Octapharma Comapny Information
8.7.2 Octapharma Business Overview
8.7.3 Octapharma Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.7.4 Octapharma Human Coagulation Factor VIII Product Portfolio
8.7.5 Octapharma Recent Developments
8.8 NovoNordisk
8.8.1 NovoNordisk Comapny Information
8.8.2 NovoNordisk Business Overview
8.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.8.4 NovoNordisk Human Coagulation Factor VIII Product Portfolio
8.8.5 NovoNordisk Recent Developments
8.9 Greencross
8.9.1 Greencross Comapny Information
8.9.2 Greencross Business Overview
8.9.3 Greencross Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.9.4 Greencross Human Coagulation Factor VIII Product Portfolio
8.9.5 Greencross Recent Developments
8.10 Kedrion
8.10.1 Kedrion Comapny Information
8.10.2 Kedrion Business Overview
8.10.3 Kedrion Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.10.4 Kedrion Human Coagulation Factor VIII Product Portfolio
8.10.5 Kedrion Recent Developments
8.11 BPL
8.11.1 BPL Comapny Information
8.11.2 BPL Business Overview
8.11.3 BPL Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.11.4 BPL Human Coagulation Factor VIII Product Portfolio
8.11.5 BPL Recent Developments
8.12 Hualan Bio
8.12.1 Hualan Bio Comapny Information
8.12.2 Hualan Bio Business Overview
8.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.12.4 Hualan Bio Human Coagulation Factor VIII Product Portfolio
8.12.5 Hualan Bio Recent Developments
8.13 RAAS
8.13.1 RAAS Comapny Information
8.13.2 RAAS Business Overview
8.13.3 RAAS Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.13.4 RAAS Human Coagulation Factor VIII Product Portfolio
8.13.5 RAAS Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Human Coagulation Factor VIII Value Chain Analysis
9.1.1 Human Coagulation Factor VIII Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Human Coagulation Factor VIII Sales Mode & Process
9.2 Human Coagulation Factor VIII Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Human Coagulation Factor VIII Distributors
9.2.3 Human Coagulation Factor VIII Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Human Coagulation Factor VIII Sales Value (2019-2030)
1.2.2 Global Human Coagulation Factor VIII Sales Volume (2019-2030)
1.2.3 Global Human Coagulation Factor VIII Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 HUMAN COAGULATION FACTOR VIII MARKET DYNAMICS
2.1 Human Coagulation Factor VIII Industry Trends
2.2 Human Coagulation Factor VIII Industry Drivers
2.3 Human Coagulation Factor VIII Industry Opportunities and Challenges
2.4 Human Coagulation Factor VIII Industry Restraints
3 HUMAN COAGULATION FACTOR VIII MARKET BY COMPANY
3.1 Global Human Coagulation Factor VIII Company Revenue Ranking in 2023
3.2 Global Human Coagulation Factor VIII Revenue by Company (2019-2024)
3.3 Global Human Coagulation Factor VIII Sales Volume by Company (2019-2024)
3.4 Global Human Coagulation Factor VIII Average Price by Company (2019-2024)
3.5 Global Human Coagulation Factor VIII Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Human Coagulation Factor VIII Company Manufacturing Base & Headquarters
3.7 Global Human Coagulation Factor VIII Company, Product Type & Application
3.8 Global Human Coagulation Factor VIII Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Human Coagulation Factor VIII Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Human Coagulation Factor VIII Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 HUMAN COAGULATION FACTOR VIII MARKET BY TYPE
4.1 Human Coagulation Factor VIII Type Introduction
4.1.1 Recombinant Factor VIII
4.1.2 Plasma-derived Factor VIII
4.2 Global Human Coagulation Factor VIII Sales Volume by Type
4.2.1 Global Human Coagulation Factor VIII Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Human Coagulation Factor VIII Sales Volume by Type (2019-2030)
4.2.3 Global Human Coagulation Factor VIII Sales Volume Share by Type (2019-2030)
4.3 Global Human Coagulation Factor VIII Sales Value by Type
4.3.1 Global Human Coagulation Factor VIII Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Human Coagulation Factor VIII Sales Value by Type (2019-2030)
4.3.3 Global Human Coagulation Factor VIII Sales Value Share by Type (2019-2030)
5 HUMAN COAGULATION FACTOR VIII MARKET BY APPLICATION
5.1 Human Coagulation Factor VIII Application Introduction
5.1.1 Hemophilia A
5.1.2 Spontanous / Trauma
5.1.3 Surgical
5.1.4 Other
5.2 Global Human Coagulation Factor VIII Sales Volume by Application
5.2.1 Global Human Coagulation Factor VIII Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Human Coagulation Factor VIII Sales Volume by Application (2019-2030)
5.2.3 Global Human Coagulation Factor VIII Sales Volume Share by Application (2019-2030)
5.3 Global Human Coagulation Factor VIII Sales Value by Application
5.3.1 Global Human Coagulation Factor VIII Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Human Coagulation Factor VIII Sales Value by Application (2019-2030)
5.3.3 Global Human Coagulation Factor VIII Sales Value Share by Application (2019-2030)
6 HUMAN COAGULATION FACTOR VIII MARKET BY REGION
6.1 Global Human Coagulation Factor VIII Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Human Coagulation Factor VIII Sales by Region (2019-2030)
6.2.1 Global Human Coagulation Factor VIII Sales by Region: 2019-2024
6.2.2 Global Human Coagulation Factor VIII Sales by Region (2025-2030)
6.3 Global Human Coagulation Factor VIII Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Human Coagulation Factor VIII Sales Value by Region (2019-2030)
6.4.1 Global Human Coagulation Factor VIII Sales Value by Region: 2019-2024
6.4.2 Global Human Coagulation Factor VIII Sales Value by Region (2025-2030)
6.5 Global Human Coagulation Factor VIII Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Human Coagulation Factor VIII Sales Value (2019-2030)
6.6.2 North America Human Coagulation Factor VIII Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Human Coagulation Factor VIII Sales Value (2019-2030)
6.7.2 Europe Human Coagulation Factor VIII Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Human Coagulation Factor VIII Sales Value (2019-2030)
6.8.2 Asia-Pacific Human Coagulation Factor VIII Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Human Coagulation Factor VIII Sales Value (2019-2030)
6.9.2 Latin America Human Coagulation Factor VIII Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Human Coagulation Factor VIII Sales Value (2019-2030)
6.10.2 Middle East & Africa Human Coagulation Factor VIII Sales Value Share by Country, 2023 VS 2030
7 HUMAN COAGULATION FACTOR VIII MARKET BY COUNTRY
7.1 Global Human Coagulation Factor VIII Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Human Coagulation Factor VIII Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Human Coagulation Factor VIII Sales by Country (2019-2030)
7.3.1 Global Human Coagulation Factor VIII Sales by Country (2019-2024)
7.3.2 Global Human Coagulation Factor VIII Sales by Country (2025-2030)
7.4 Global Human Coagulation Factor VIII Sales Value by Country (2019-2030)
7.4.1 Global Human Coagulation Factor VIII Sales Value by Country (2019-2024)
7.4.2 Global Human Coagulation Factor VIII Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.5.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.6.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.7.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.8.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.9.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.10.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.11.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.12.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.13.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.14.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.15.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.16.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.17.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.18.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.19.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.20.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.21.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.22.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030)
7.23.2 Global Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Shire (Baxter)
8.1.1 Shire (Baxter) Comapny Information
8.1.2 Shire (Baxter) Business Overview
8.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.1.4 Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
8.1.5 Shire (Baxter) Recent Developments
8.2 Bayer
8.2.1 Bayer Comapny Information
8.2.2 Bayer Business Overview
8.2.3 Bayer Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.2.4 Bayer Human Coagulation Factor VIII Product Portfolio
8.2.5 Bayer Recent Developments
8.3 CSL
8.3.1 CSL Comapny Information
8.3.2 CSL Business Overview
8.3.3 CSL Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.3.4 CSL Human Coagulation Factor VIII Product Portfolio
8.3.5 CSL Recent Developments
8.4 Pfizer
8.4.1 Pfizer Comapny Information
8.4.2 Pfizer Business Overview
8.4.3 Pfizer Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.4.4 Pfizer Human Coagulation Factor VIII Product Portfolio
8.4.5 Pfizer Recent Developments
8.5 Grifols
8.5.1 Grifols Comapny Information
8.5.2 Grifols Business Overview
8.5.3 Grifols Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.5.4 Grifols Human Coagulation Factor VIII Product Portfolio
8.5.5 Grifols Recent Developments
8.6 Biogen
8.6.1 Biogen Comapny Information
8.6.2 Biogen Business Overview
8.6.3 Biogen Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.6.4 Biogen Human Coagulation Factor VIII Product Portfolio
8.6.5 Biogen Recent Developments
8.7 Octapharma
8.7.1 Octapharma Comapny Information
8.7.2 Octapharma Business Overview
8.7.3 Octapharma Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.7.4 Octapharma Human Coagulation Factor VIII Product Portfolio
8.7.5 Octapharma Recent Developments
8.8 NovoNordisk
8.8.1 NovoNordisk Comapny Information
8.8.2 NovoNordisk Business Overview
8.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.8.4 NovoNordisk Human Coagulation Factor VIII Product Portfolio
8.8.5 NovoNordisk Recent Developments
8.9 Greencross
8.9.1 Greencross Comapny Information
8.9.2 Greencross Business Overview
8.9.3 Greencross Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.9.4 Greencross Human Coagulation Factor VIII Product Portfolio
8.9.5 Greencross Recent Developments
8.10 Kedrion
8.10.1 Kedrion Comapny Information
8.10.2 Kedrion Business Overview
8.10.3 Kedrion Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.10.4 Kedrion Human Coagulation Factor VIII Product Portfolio
8.10.5 Kedrion Recent Developments
8.11 BPL
8.11.1 BPL Comapny Information
8.11.2 BPL Business Overview
8.11.3 BPL Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.11.4 BPL Human Coagulation Factor VIII Product Portfolio
8.11.5 BPL Recent Developments
8.12 Hualan Bio
8.12.1 Hualan Bio Comapny Information
8.12.2 Hualan Bio Business Overview
8.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.12.4 Hualan Bio Human Coagulation Factor VIII Product Portfolio
8.12.5 Hualan Bio Recent Developments
8.13 RAAS
8.13.1 RAAS Comapny Information
8.13.2 RAAS Business Overview
8.13.3 RAAS Human Coagulation Factor VIII Sales, Value and Gross Margin (2019-2024)
8.13.4 RAAS Human Coagulation Factor VIII Product Portfolio
8.13.5 RAAS Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Human Coagulation Factor VIII Value Chain Analysis
9.1.1 Human Coagulation Factor VIII Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Human Coagulation Factor VIII Sales Mode & Process
9.2 Human Coagulation Factor VIII Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Human Coagulation Factor VIII Distributors
9.2.3 Human Coagulation Factor VIII Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
LIST OF TABLES
Table 1. Human Coagulation Factor VIII Industry Trends
Table 2. Human Coagulation Factor VIII Industry Drivers
Table 3. Human Coagulation Factor VIII Industry Opportunities and Challenges
Table 4. Human Coagulation Factor VIII Industry Restraints
Table 5. Global Human Coagulation Factor VIII Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Human Coagulation Factor VIII Revenue Share by Company (2019-2024)
Table 7. Global Human Coagulation Factor VIII Sales Volume by Company (K Bottles) & (2019-2024)
Table 8. Global Human Coagulation Factor VIII Sales Volume Share by Company (2019-2024)
Table 9. Global Human Coagulation Factor VIII Average Price (USD/Bottle) of Company (2019-2024)
Table 10. Global Human Coagulation Factor VIII Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 11. Global Human Coagulation Factor VIII Key Company Manufacturing Base & Headquarters
Table 12. Global Human Coagulation Factor VIII Company, Product Type & Application
Table 13. Global Human Coagulation Factor VIII Company Commercialization Time
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Human Coagulation Factor VIII by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Major Companies of Recombinant Factor VIII
Table 18. Major Companies of Plasma-derived Factor VIII
Table 19. Global Human Coagulation Factor VIII Sales Volume by Type 2019 VS 2023 VS 2030 (K Bottles)
Table 20. Global Human Coagulation Factor VIII Sales Volume by Type (2019-2024) & (K Bottles)
Table 21. Global Human Coagulation Factor VIII Sales Volume by Type (2025-2030) & (K Bottles)
Table 22. Global Human Coagulation Factor VIII Sales Volume Share by Type (2019-2024)
Table 23. Global Human Coagulation Factor VIII Sales Volume Share by Type (2025-2030)
Table 24. Global Human Coagulation Factor VIII Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Human Coagulation Factor VIII Sales Value by Type (2019-2024) & (US$ Million)
Table 26. Global Human Coagulation Factor VIII Sales Value by Type (2025-2030) & (US$ Million)
Table 27. Global Human Coagulation Factor VIII Sales Value Share by Type (2019-2024)
Table 28. Global Human Coagulation Factor VIII Sales Value Share by Type (2025-2030)
Table 29. Major Companies of Hemophilia A
Table 30. Major Companies of Spontanous / Trauma
Table 31. Major Companies of Surgical
Table 32. Major Companies of Other
Table 33. Global Human Coagulation Factor VIII Sales Volume by Application 2019 VS 2023 VS 2030 (K Bottles)
Table 34. Global Human Coagulation Factor VIII Sales Volume by Application (2019-2024) & (K Bottles)
Table 35. Global Human Coagulation Factor VIII Sales Volume by Application (2025-2030) & (K Bottles)
Table 36. Global Human Coagulation Factor VIII Sales Volume Share by Application (2019-2024)
Table 37. Global Human Coagulation Factor VIII Sales Volume Share by Application (2025-2030)
Table 38. Global Human Coagulation Factor VIII Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 39. Global Human Coagulation Factor VIII Sales Value by Application (2019-2024) & (US$ Million)
Table 40. Global Human Coagulation Factor VIII Sales Value by Application (2025-2030) & (US$ Million)
Table 41. Global Human Coagulation Factor VIII Sales Value Share by Application (2019-2024)
Table 42. Global Human Coagulation Factor VIII Sales Value Share by Application (2025-2030)
Table 43. Global Human Coagulation Factor VIII Sales by Region: 2019 VS 2023 VS 2030 (K Bottles)
Table 44. Global Human Coagulation Factor VIII Sales by Region (2019-2024) & (K Bottles)
Table 45. Global Human Coagulation Factor VIII Sales Market Share by Region (2019-2024)
Table 46. Global Human Coagulation Factor VIII Sales by Region (2025-2030) & (K Bottles)
Table 47. Global Human Coagulation Factor VIII Sales Market Share by Region (2025-2030)
Table 48. Global Human Coagulation Factor VIII Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 49. Global Human Coagulation Factor VIII Sales Value by Region (2019-2024) & (US$ Million)
Table 50. Global Human Coagulation Factor VIII Sales Value Share by Region (2019-2024)
Table 51. Global Human Coagulation Factor VIII Sales Value by Region (2025-2030) & (US$ Million)
Table 52. Global Human Coagulation Factor VIII Sales Value Share by Region (2025-2030)
Table 53. Global Human Coagulation Factor VIII Market Average Price (USD/Bottle) by Region (2019-2024)
Table 54. Global Human Coagulation Factor VIII Market Average Price (USD/Bottle) by Region (2025-2030)
Table 55. Global Human Coagulation Factor VIII Sales by Country: 2019 VS 2023 VS 2030 (K Bottles)
Table 56. Global Human Coagulation Factor VIII Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 57. Global Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)
Table 58. Global Human Coagulation Factor VIII Sales Market Share by Country (2019-2024)
Table 59. Global Human Coagulation Factor VIII Sales by Country (2025-2030) & (K Bottles)
Table 60. Global Human Coagulation Factor VIII Sales Market Share by Country (2025-2030)
Table 61. Global Human Coagulation Factor VIII Sales Value by Country (2019-2024) & (US$ Million)
Table 62. Global Human Coagulation Factor VIII Sales Value Market Share by Country (2019-2024)
Table 63. Global Human Coagulation Factor VIII Sales Value by Country (2025-2030) & (US$ Million)
Table 64. Global Human Coagulation Factor VIII Sales Value Market Share by Country (2025-2030)
Table 65. Shire (Baxter) Company Information
Table 66. Shire (Baxter) Business Overview
Table 67. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 68. Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
Table 69. Shire (Baxter) Recent Development
Table 70. Bayer Company Information
Table 71. Bayer Business Overview
Table 72. Bayer Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 73. Bayer Human Coagulation Factor VIII Product Portfolio
Table 74. Bayer Recent Development
Table 75. CSL Company Information
Table 76. CSL Business Overview
Table 77. CSL Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 78. CSL Human Coagulation Factor VIII Product Portfolio
Table 79. CSL Recent Development
Table 80. Pfizer Company Information
Table 81. Pfizer Business Overview
Table 82. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 83. Pfizer Human Coagulation Factor VIII Product Portfolio
Table 84. Pfizer Recent Development
Table 85. Grifols Company Information
Table 86. Grifols Business Overview
Table 87. Grifols Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 88. Grifols Human Coagulation Factor VIII Product Portfolio
Table 89. Grifols Recent Development
Table 90. Biogen Company Information
Table 91. Biogen Business Overview
Table 92. Biogen Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 93. Biogen Human Coagulation Factor VIII Product Portfolio
Table 94. Biogen Recent Development
Table 95. Octapharma Company Information
Table 96. Octapharma Business Overview
Table 97. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 98. Octapharma Human Coagulation Factor VIII Product Portfolio
Table 99. Octapharma Recent Development
Table 100. NovoNordisk Company Information
Table 101. NovoNordisk Business Overview
Table 102. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 103. NovoNordisk Human Coagulation Factor VIII Product Portfolio
Table 104. NovoNordisk Recent Development
Table 105. Greencross Company Information
Table 106. Greencross Business Overview
Table 107. Greencross Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 108. Greencross Human Coagulation Factor VIII Product Portfolio
Table 109. Greencross Recent Development
Table 110. Kedrion Company Information
Table 111. Kedrion Business Overview
Table 112. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 113. Kedrion Human Coagulation Factor VIII Product Portfolio
Table 114. Kedrion Recent Development
Table 115. BPL Company Information
Table 116. BPL Business Overview
Table 117. BPL Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 118. BPL Human Coagulation Factor VIII Product Portfolio
Table 119. BPL Recent Development
Table 120. Hualan Bio Company Information
Table 121. Hualan Bio Business Overview
Table 122. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 123. Hualan Bio Human Coagulation Factor VIII Product Portfolio
Table 124. Hualan Bio Recent Development
Table 125. RAAS Company Information
Table 126. RAAS Business Overview
Table 127. RAAS Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 128. RAAS Human Coagulation Factor VIII Product Portfolio
Table 129. RAAS Recent Development
Table 130. Key Raw Materials
Table 131. Raw Materials Key Suppliers
Table 132. Human Coagulation Factor VIII Distributors List
Table 133. Human Coagulation Factor VIII Customers List
Table 134. Research Programs/Design for This Report
Table 135. Authors List of This Report
Table 136. Secondary Sources
Table 137. Primary Sources
Table 1. Human Coagulation Factor VIII Industry Trends
Table 2. Human Coagulation Factor VIII Industry Drivers
Table 3. Human Coagulation Factor VIII Industry Opportunities and Challenges
Table 4. Human Coagulation Factor VIII Industry Restraints
Table 5. Global Human Coagulation Factor VIII Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Human Coagulation Factor VIII Revenue Share by Company (2019-2024)
Table 7. Global Human Coagulation Factor VIII Sales Volume by Company (K Bottles) & (2019-2024)
Table 8. Global Human Coagulation Factor VIII Sales Volume Share by Company (2019-2024)
Table 9. Global Human Coagulation Factor VIII Average Price (USD/Bottle) of Company (2019-2024)
Table 10. Global Human Coagulation Factor VIII Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 11. Global Human Coagulation Factor VIII Key Company Manufacturing Base & Headquarters
Table 12. Global Human Coagulation Factor VIII Company, Product Type & Application
Table 13. Global Human Coagulation Factor VIII Company Commercialization Time
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Human Coagulation Factor VIII by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Major Companies of Recombinant Factor VIII
Table 18. Major Companies of Plasma-derived Factor VIII
Table 19. Global Human Coagulation Factor VIII Sales Volume by Type 2019 VS 2023 VS 2030 (K Bottles)
Table 20. Global Human Coagulation Factor VIII Sales Volume by Type (2019-2024) & (K Bottles)
Table 21. Global Human Coagulation Factor VIII Sales Volume by Type (2025-2030) & (K Bottles)
Table 22. Global Human Coagulation Factor VIII Sales Volume Share by Type (2019-2024)
Table 23. Global Human Coagulation Factor VIII Sales Volume Share by Type (2025-2030)
Table 24. Global Human Coagulation Factor VIII Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Human Coagulation Factor VIII Sales Value by Type (2019-2024) & (US$ Million)
Table 26. Global Human Coagulation Factor VIII Sales Value by Type (2025-2030) & (US$ Million)
Table 27. Global Human Coagulation Factor VIII Sales Value Share by Type (2019-2024)
Table 28. Global Human Coagulation Factor VIII Sales Value Share by Type (2025-2030)
Table 29. Major Companies of Hemophilia A
Table 30. Major Companies of Spontanous / Trauma
Table 31. Major Companies of Surgical
Table 32. Major Companies of Other
Table 33. Global Human Coagulation Factor VIII Sales Volume by Application 2019 VS 2023 VS 2030 (K Bottles)
Table 34. Global Human Coagulation Factor VIII Sales Volume by Application (2019-2024) & (K Bottles)
Table 35. Global Human Coagulation Factor VIII Sales Volume by Application (2025-2030) & (K Bottles)
Table 36. Global Human Coagulation Factor VIII Sales Volume Share by Application (2019-2024)
Table 37. Global Human Coagulation Factor VIII Sales Volume Share by Application (2025-2030)
Table 38. Global Human Coagulation Factor VIII Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 39. Global Human Coagulation Factor VIII Sales Value by Application (2019-2024) & (US$ Million)
Table 40. Global Human Coagulation Factor VIII Sales Value by Application (2025-2030) & (US$ Million)
Table 41. Global Human Coagulation Factor VIII Sales Value Share by Application (2019-2024)
Table 42. Global Human Coagulation Factor VIII Sales Value Share by Application (2025-2030)
Table 43. Global Human Coagulation Factor VIII Sales by Region: 2019 VS 2023 VS 2030 (K Bottles)
Table 44. Global Human Coagulation Factor VIII Sales by Region (2019-2024) & (K Bottles)
Table 45. Global Human Coagulation Factor VIII Sales Market Share by Region (2019-2024)
Table 46. Global Human Coagulation Factor VIII Sales by Region (2025-2030) & (K Bottles)
Table 47. Global Human Coagulation Factor VIII Sales Market Share by Region (2025-2030)
Table 48. Global Human Coagulation Factor VIII Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 49. Global Human Coagulation Factor VIII Sales Value by Region (2019-2024) & (US$ Million)
Table 50. Global Human Coagulation Factor VIII Sales Value Share by Region (2019-2024)
Table 51. Global Human Coagulation Factor VIII Sales Value by Region (2025-2030) & (US$ Million)
Table 52. Global Human Coagulation Factor VIII Sales Value Share by Region (2025-2030)
Table 53. Global Human Coagulation Factor VIII Market Average Price (USD/Bottle) by Region (2019-2024)
Table 54. Global Human Coagulation Factor VIII Market Average Price (USD/Bottle) by Region (2025-2030)
Table 55. Global Human Coagulation Factor VIII Sales by Country: 2019 VS 2023 VS 2030 (K Bottles)
Table 56. Global Human Coagulation Factor VIII Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 57. Global Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)
Table 58. Global Human Coagulation Factor VIII Sales Market Share by Country (2019-2024)
Table 59. Global Human Coagulation Factor VIII Sales by Country (2025-2030) & (K Bottles)
Table 60. Global Human Coagulation Factor VIII Sales Market Share by Country (2025-2030)
Table 61. Global Human Coagulation Factor VIII Sales Value by Country (2019-2024) & (US$ Million)
Table 62. Global Human Coagulation Factor VIII Sales Value Market Share by Country (2019-2024)
Table 63. Global Human Coagulation Factor VIII Sales Value by Country (2025-2030) & (US$ Million)
Table 64. Global Human Coagulation Factor VIII Sales Value Market Share by Country (2025-2030)
Table 65. Shire (Baxter) Company Information
Table 66. Shire (Baxter) Business Overview
Table 67. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 68. Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
Table 69. Shire (Baxter) Recent Development
Table 70. Bayer Company Information
Table 71. Bayer Business Overview
Table 72. Bayer Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 73. Bayer Human Coagulation Factor VIII Product Portfolio
Table 74. Bayer Recent Development
Table 75. CSL Company Information
Table 76. CSL Business Overview
Table 77. CSL Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 78. CSL Human Coagulation Factor VIII Product Portfolio
Table 79. CSL Recent Development
Table 80. Pfizer Company Information
Table 81. Pfizer Business Overview
Table 82. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 83. Pfizer Human Coagulation Factor VIII Product Portfolio
Table 84. Pfizer Recent Development
Table 85. Grifols Company Information
Table 86. Grifols Business Overview
Table 87. Grifols Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 88. Grifols Human Coagulation Factor VIII Product Portfolio
Table 89. Grifols Recent Development
Table 90. Biogen Company Information
Table 91. Biogen Business Overview
Table 92. Biogen Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 93. Biogen Human Coagulation Factor VIII Product Portfolio
Table 94. Biogen Recent Development
Table 95. Octapharma Company Information
Table 96. Octapharma Business Overview
Table 97. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 98. Octapharma Human Coagulation Factor VIII Product Portfolio
Table 99. Octapharma Recent Development
Table 100. NovoNordisk Company Information
Table 101. NovoNordisk Business Overview
Table 102. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 103. NovoNordisk Human Coagulation Factor VIII Product Portfolio
Table 104. NovoNordisk Recent Development
Table 105. Greencross Company Information
Table 106. Greencross Business Overview
Table 107. Greencross Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 108. Greencross Human Coagulation Factor VIII Product Portfolio
Table 109. Greencross Recent Development
Table 110. Kedrion Company Information
Table 111. Kedrion Business Overview
Table 112. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 113. Kedrion Human Coagulation Factor VIII Product Portfolio
Table 114. Kedrion Recent Development
Table 115. BPL Company Information
Table 116. BPL Business Overview
Table 117. BPL Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 118. BPL Human Coagulation Factor VIII Product Portfolio
Table 119. BPL Recent Development
Table 120. Hualan Bio Company Information
Table 121. Hualan Bio Business Overview
Table 122. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 123. Hualan Bio Human Coagulation Factor VIII Product Portfolio
Table 124. Hualan Bio Recent Development
Table 125. RAAS Company Information
Table 126. RAAS Business Overview
Table 127. RAAS Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 128. RAAS Human Coagulation Factor VIII Product Portfolio
Table 129. RAAS Recent Development
Table 130. Key Raw Materials
Table 131. Raw Materials Key Suppliers
Table 132. Human Coagulation Factor VIII Distributors List
Table 133. Human Coagulation Factor VIII Customers List
Table 134. Research Programs/Design for This Report
Table 135. Authors List of This Report
Table 136. Secondary Sources
Table 137. Primary Sources
LIST OF FIGURES
Figure 1. Human Coagulation Factor VIII Product Picture
Figure 2. Global Human Coagulation Factor VIII Sales Value (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Human Coagulation Factor VIII Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Human Coagulation Factor VIII Sales (2019-2030) & (K Bottles)
Figure 5. Global Human Coagulation Factor VIII Sales Average Price (USD/Bottle) & (2019-2030)
Figure 6. Global Human Coagulation Factor VIII Company Revenue Ranking in 2023 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 9. Recombinant Factor VIII Picture
Figure 10. Plasma-derived Factor VIII Picture
Figure 11. Global Human Coagulation Factor VIII Sales Volume by Type (2019 VS 2023 VS 2030) & (K Bottles)
Figure 12. Global Human Coagulation Factor VIII Sales Volume Share 2019 VS 2023 VS 2030
Figure 13. Global Human Coagulation Factor VIII Sales Volume Share by Type (2019-2030)
Figure 14. Global Human Coagulation Factor VIII Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Human Coagulation Factor VIII Sales Value Share 2019 VS 2023 VS 2030
Figure 16. Global Human Coagulation Factor VIII Sales Value Share by Type (2019-2030)
Figure 17. Hemophilia A Picture
Figure 18. Spontanous / Trauma Picture
Figure 19. Surgical Picture
Figure 20. Other Picture
Figure 21. Global Human Coagulation Factor VIII Sales Volume by Application (2019 VS 2023 VS 2030) & (K Bottles)
Figure 22. Global Human Coagulation Factor VIII Sales Volume Share 2019 VS 2023 VS 2030
Figure 23. Global Human Coagulation Factor VIII Sales Volume Share by Application (2019-2030)
Figure 24. Global Human Coagulation Factor VIII Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 25. Global Human Coagulation Factor VIII Sales Value Share 2019 VS 2023 VS 2030
Figure 26. Global Human Coagulation Factor VIII Sales Value Share by Application (2019-2030)
Figure 27. Global Human Coagulation Factor VIII Sales by Region: 2019 VS 2023 VS 2030 (K Bottles)
Figure 28. Global Human Coagulation Factor VIII Sales Market Share by Region: 2019 VS 2023 VS 2030
Figure 29. Global Human Coagulation Factor VIII Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 30. Global Human Coagulation Factor VIII Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 31. North America Human Coagulation Factor VIII Sales Value (2019-2030) & (US$ Million)
Figure 32. North America Human Coagulation Factor VIII Sales Value Share by Country (%), 2023 VS 2030
Figure 33. Europe Human Coagulation Factor VIII Sales Value (2019-2030) & (US$ Million)
Figure 34. Europe Human Coagulation Factor VIII Sales Value Share by Country (%), 2023 VS 2030
Figure 35. Asia-Pacific Human Coagulation Factor VIII Sales Value (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Human Coagulation Factor VIII Sales Value Share by Country (%), 2023 VS 2030
Figure 37. Latin America Human Coagulation Factor VIII Sales Value (2019-2030) & (US$ Million)
Figure 38. Latin America Human Coagulation Factor VIII Sales Value Share by Country (%), 2023 VS 2030
Figure 39. Middle East & Africa Human Coagulation Factor VIII Sales Value (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Human Coagulation Factor VIII Sales Value Share by Country (%), 2023 VS 2030
Figure 41. USA Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 42. USA Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 43. USA Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 44. Canada Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 45. Canada Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 46. Canada Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 47. Germany Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 48. Germany Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 49. Germany Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 50. France Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 51. France Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 52. France Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 53. U.K. Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.K. Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 55. U.K. Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 56. Italy Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 57. Italy Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 58. Italy Human Coagulation Factor VIII Sales Value Share by Applica
Figure 1. Human Coagulation Factor VIII Product Picture
Figure 2. Global Human Coagulation Factor VIII Sales Value (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Human Coagulation Factor VIII Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Human Coagulation Factor VIII Sales (2019-2030) & (K Bottles)
Figure 5. Global Human Coagulation Factor VIII Sales Average Price (USD/Bottle) & (2019-2030)
Figure 6. Global Human Coagulation Factor VIII Company Revenue Ranking in 2023 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 9. Recombinant Factor VIII Picture
Figure 10. Plasma-derived Factor VIII Picture
Figure 11. Global Human Coagulation Factor VIII Sales Volume by Type (2019 VS 2023 VS 2030) & (K Bottles)
Figure 12. Global Human Coagulation Factor VIII Sales Volume Share 2019 VS 2023 VS 2030
Figure 13. Global Human Coagulation Factor VIII Sales Volume Share by Type (2019-2030)
Figure 14. Global Human Coagulation Factor VIII Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Human Coagulation Factor VIII Sales Value Share 2019 VS 2023 VS 2030
Figure 16. Global Human Coagulation Factor VIII Sales Value Share by Type (2019-2030)
Figure 17. Hemophilia A Picture
Figure 18. Spontanous / Trauma Picture
Figure 19. Surgical Picture
Figure 20. Other Picture
Figure 21. Global Human Coagulation Factor VIII Sales Volume by Application (2019 VS 2023 VS 2030) & (K Bottles)
Figure 22. Global Human Coagulation Factor VIII Sales Volume Share 2019 VS 2023 VS 2030
Figure 23. Global Human Coagulation Factor VIII Sales Volume Share by Application (2019-2030)
Figure 24. Global Human Coagulation Factor VIII Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 25. Global Human Coagulation Factor VIII Sales Value Share 2019 VS 2023 VS 2030
Figure 26. Global Human Coagulation Factor VIII Sales Value Share by Application (2019-2030)
Figure 27. Global Human Coagulation Factor VIII Sales by Region: 2019 VS 2023 VS 2030 (K Bottles)
Figure 28. Global Human Coagulation Factor VIII Sales Market Share by Region: 2019 VS 2023 VS 2030
Figure 29. Global Human Coagulation Factor VIII Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 30. Global Human Coagulation Factor VIII Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 31. North America Human Coagulation Factor VIII Sales Value (2019-2030) & (US$ Million)
Figure 32. North America Human Coagulation Factor VIII Sales Value Share by Country (%), 2023 VS 2030
Figure 33. Europe Human Coagulation Factor VIII Sales Value (2019-2030) & (US$ Million)
Figure 34. Europe Human Coagulation Factor VIII Sales Value Share by Country (%), 2023 VS 2030
Figure 35. Asia-Pacific Human Coagulation Factor VIII Sales Value (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Human Coagulation Factor VIII Sales Value Share by Country (%), 2023 VS 2030
Figure 37. Latin America Human Coagulation Factor VIII Sales Value (2019-2030) & (US$ Million)
Figure 38. Latin America Human Coagulation Factor VIII Sales Value Share by Country (%), 2023 VS 2030
Figure 39. Middle East & Africa Human Coagulation Factor VIII Sales Value (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Human Coagulation Factor VIII Sales Value Share by Country (%), 2023 VS 2030
Figure 41. USA Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 42. USA Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 43. USA Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 44. Canada Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 45. Canada Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 46. Canada Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 47. Germany Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 48. Germany Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 49. Germany Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 50. France Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 51. France Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 52. France Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 53. U.K. Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.K. Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 55. U.K. Human Coagulation Factor VIII Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 56. Italy Human Coagulation Factor VIII Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 57. Italy Human Coagulation Factor VIII Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 58. Italy Human Coagulation Factor VIII Sales Value Share by Applica
